Citigroup Forecasts Strong Price Appreciation for Informa (LON:INF) Stock

Informa (LON:INF) had its price target upped by Citigroup from GBX 975 to GBX 1,000 in a research report issued on Thursday, MarketBeat reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price suggests a potential upside of 7.04% from the stock’s current price.

Other equities research analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft raised their price target on Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. cut their target price on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a report on Monday, January 12th. Panmure Gordon reiterated a “buy” rating and issued a GBX 1,200 target price on shares of Informa in a research note on Wednesday, November 19th. UBS Group reiterated a “buy” rating and issued a GBX 1,055 target price on shares of Informa in a report on Friday, November 7th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 1,030 target price on shares of Informa in a research report on Wednesday. Six research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,097.86.

Informa Trading Down 0.4%

LON:INF opened at GBX 934.26 on Thursday. The stock has a market cap of £11.95 billion, a PE ratio of 169.86, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. Informa has a fifty-two week low of GBX 634.20 and a fifty-two week high of GBX 1,000. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70. The stock’s 50-day moving average is GBX 906.04 and its two-hundred day moving average is GBX 902.30.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.